ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

LMNX Luminex Corporation

36.99
0.00 (0.00%)
After Hours
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Luminex Corporation NASDAQ:LMNX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 36.99 36.94 36.98 0 01:00:00

- Current report filing (8-K)

11/01/2010 10:01pm

Edgar (US Regulatory)


 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 11, 2010 (January 11, 2010)

LUMINEX CORPORATION
(Exact name of registrant as specified in its charter)

         
DELAWARE   000-30109   74-2747608
(State or other Jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)
     
12212 TECHNOLOGY BLVD., AUSTIN, TEXAS
  78727
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: (512) 219-8020

 
N/A
(Former name or former address if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

 

1


 

Item 2.02. Results of Operations and Financial Condition.

This update is provided in anticipation of Luminex Corporation’s participation at the JPMorgan Healthcare Conference. Luminex is adjusting its 2009 full year projected revenue guidance to between $119 to $121 million from the most recent projected revenue guidance of between $118 and $126 million reported by Luminex on November 4, 2009.

 

2


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

           
Date: January 11, 2010   LUMINEX CORPORATION  
           
 
  By:   /s/ Harriss T. Currie  
 
         
 
  Name:
Title:
  Harriss T. Currie
Vice President, Finance, Chief
Financial Officer and Treasurer
 

 

3

1 Year Luminex Chart

1 Year Luminex Chart

1 Month Luminex Chart

1 Month Luminex Chart

Your Recent History

Delayed Upgrade Clock